A citation-based method for searching scientific literature

Chiara Elena, Anna Gallì, Elisa Bono, Gabriele Todisco, Luca Malcovati. Curr Opin Hematol 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS.
A Porwit, A A van de Loosdrecht, P Bettelheim, L Eidenschink Brodersen, K Burbury, E Cremers, M G Della Porta, R Ireland, U Johansson, S Matarraz,[...]. Leukemia 2014
77
100

Prophylactic or Preemptive Low-Dose Azacitidine and Donor Lymphocyte Infusion to Prevent Disease Relapse following Allogeneic Transplantation in Patients with High-Risk Acute Myelogenous Leukemia or Myelodysplastic Syndrome.
Thierry Guillaume, Sylvain Thépot, Pierre Peterlin, Patrice Ceballos, Amandine Le Bourgeois, Alice Garnier, Corentin Orvain, Aurélien Giltat, Sylvie François, Yannick Le Bris,[...]. Transplant Cell Ther 2021
1
100

Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†☆.
P Fenaux, D Haase, V Santini, G F Sanz, U Platzbecker, U Mey. Ann Oncol 2021
9
100

Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers.
Eric J Duncavage, Molly C Schroeder, Michele O'Laughlin, Roxanne Wilson, Sandra MacMillan, Andrew Bohannon, Scott Kruchowski, John Garza, Feiyu Du, Andrew E O Hughes,[...]. N Engl J Med 2021
20
100

Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes: A Randomized Trial.
Emanuele Angelucci, Junmin Li, Peter Greenberg, Depei Wu, Ming Hou, Efreen Horacio Montano Figueroa, Maria Guadalupe Rodriguez, Xunwei Dong, Jagannath Ghosh, Miguel Izquierdo,[...]. Ann Intern Med 2020
32
100

Advances in germline predisposition to acute leukaemias and myeloid neoplasms.
Jeffery M Klco, Charles G Mullighan. Nat Rev Cancer 2021
18
100

Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes.
Matteo Bersanelli, Erica Travaglino, Manja Meggendorfer, Tommaso Matteuzzi, Claudia Sala, Ettore Mosca, Chiara Chiereghin, Noemi Di Nanni, Matteo Gnocchi, Matteo Zampini,[...]. J Clin Oncol 2021
13
100

Enasidenib in patients with mutant IDH2 myelodysplastic syndromes: a phase 1 subgroup analysis of the multicentre, AG221-C-001 trial.
Eytan M Stein, Amir T Fathi, Courtney D DiNardo, Daniel A Pollyea, Gail J Roboz, Robert Collins, Mikkael A Sekeres, Richard M Stone, Eyal C Attar, Mark G Frattini,[...]. Lancet Haematol 2020
33
100

Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission.
Andrew H Wei, Hartmut Döhner, Christopher Pocock, Pau Montesinos, Boris Afanasyev, Hervé Dombret, Farhad Ravandi, Hamid Sayar, Jun-Ho Jang, Kimmo Porkka,[...]. N Engl J Med 2020
63
100

Phase II Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Myelodysplastic Syndromes.
Valeria Santini, David Valcárcel, Uwe Platzbecker, Rami S Komrokji, Ann L Cleverly, Michael M Lahn, Jan Janssen, Yumin Zhao, Alan Chiang, Aristoteles Giagounidis,[...]. Clin Cancer Res 2019
25
100

Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes.
Pierre Fenaux, Uwe Platzbecker, Ghulam J Mufti, Guillermo Garcia-Manero, Rena Buckstein, Valeria Santini, María Díez-Campelo, Carlo Finelli, Mario Cazzola, Osman Ilhan,[...]. N Engl J Med 2020
135
100

Eprenetapopt Plus Azacitidine in TP53-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM).
Thomas Cluzeau, Marie Sebert, Ramy Rahmé, Stefania Cuzzubbo, Jacqueline Lehmann-Che, Isabelle Madelaine, Pierre Peterlin, Blandine Bève, Habiba Attalah, Fatiha Chermat,[...]. J Clin Oncol 2021
22
100

SARS-CoV-2 in Myelodysplastic Syndromes: A Snapshot From Early Italian Experience.
Sandra Mossuto, Enrico Attardi, Francesco Alesiani, Emanuele Angelucci, Enrico Balleari, Massimo Bernardi, Gianni Binotto, Costanza Bosi, Anna Calvisi, Isabella Capodanno,[...]. Hemasphere 2020
2
100

Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation.
Matteo G Della Porta, Anna Gallì, Andrea Bacigalupo, Silvia Zibellini, Massimo Bernardi, Ettore Rizzo, Bernardino Allione, Maria Teresa van Lint, Pietro Pioltelli, Paola Marenco,[...]. J Clin Oncol 2016
129
100

Clinical relevance of clonal hematopoiesis in persons aged ≥80 years.
Marianna Rossi, Manja Meggendorfer, Matteo Zampini, Mauro Tettamanti, Emma Riva, Erica Travaglino, Matteo Bersanelli, Sara Mandelli, Alessia Antonella Galbussera, Ettore Mosca,[...]. Blood 2021
2
100

Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study.
David P Steensma, Pierre Fenaux, Koen Van Eygen, Azra Raza, Valeria Santini, Ulrich Germing, Patricia Font, Maria Diez-Campelo, Sylvain Thepot, Edo Vellenga,[...]. J Clin Oncol 2021
21
100

Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents.
Sophie Park, Jean-François Hamel, Andrea Toma, Charikleia Kelaidi, Sylvain Thépot, Maria Diez Campelo, Valeria Santini, Mikkael A Sekeres, Enrico Balleari, Jennifer Kaivers,[...]. J Clin Oncol 2017
50
100

Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes.
David A Sallman, Amy E DeZern, Guillermo Garcia-Manero, David P Steensma, Gail J Roboz, Mikkael A Sekeres, Thomas Cluzeau, Kendra L Sweet, Amy McLemore, Kathy L McGraw,[...]. J Clin Oncol 2021
42
100

Computational flow cytometry as a diagnostic tool in suspected-myelodysplastic syndromes.
Carolien Duetz, Sofie Van Gassen, Theresia M Westers, Margot F van Spronsen, Costa Bachas, Yvan Saeys, Arjan A van de Loosdrecht. Cytometry A 2021
2
100

Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover study.
Guillermo Garcia-Manero, Elizabeth A Griffiths, David P Steensma, Gail J Roboz, Richard Wells, James McCloskey, Olatoyosi Odenike, Amy E DeZern, Karen Yee, Lambert Busque,[...]. Blood 2020
54
100

Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML.
Mikkael A Sekeres, Justin Watts, Atanas Radinoff, Montserrat Arnan Sangerman, Marco Cerrano, Patricia Font Lopez, Joshua F Zeidner, Maria Diez Campelo, Carlos Graux, Jane Liesveld,[...]. Leukemia 2021
12
100

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts.
Amer M Zeidan, Prajwal C Boddu, Mrinal M Patnaik, Jan Philipp Bewersdorf, Maximilian Stahl, Raajit K Rampal, Rory Shallis, David P Steensma, Michael R Savona, Mikkael A Sekeres,[...]. Lancet Haematol 2020
39
100

Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic Syndromes.
Guillermo Garcia-Manero, Valeria Santini, Antonio Almeida, Uwe Platzbecker, Anna Jonasova, Lewis R Silverman, Jose Falantes, Gianluigi Reda, Francesco Buccisano, Pierre Fenaux,[...]. J Clin Oncol 2021
8
100

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.
Elsa Bernard, Yasuhito Nannya, Robert P Hasserjian, Sean M Devlin, Heinz Tuechler, Juan S Medina-Martinez, Tetsuichi Yoshizato, Yusuke Shiozawa, Ryunosuke Saiki, Luca Malcovati,[...]. Nat Med 2020
80
100

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
Daniel A Arber, Attilio Orazi, Robert Hasserjian, Jürgen Thiele, Michael J Borowitz, Michelle M Le Beau, Clara D Bloomfield, Mario Cazzola, James W Vardiman. Blood 2016
100

Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome.
Hsin-An Hou, Cheng-Hong Tsai, Chien-Chin Lin, Wen-Chien Chou, Yuan-Yeh Kuo, Chieh-Yu Liu, Mei-Hsuan Tseng, Yen-Ling Peng, Ming-Chih Liu, Chia-Wen Liu,[...]. Blood Cancer J 2018
41
100

Decitabine/Cedazuridine: First Approval.
Sohita Dhillon. Drugs 2020
12
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.